• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

Dolores “Dee” Holden Norris (1946–2025), Ted’s wife, championed the award and the standards of clinical excellence it represents. In December 2025, the International Alliance paid tribute to Dee — nurse, advocate, co-founder of the Alliance, and a driving force behind the multidisciplinary model of ALS/MND care.

Working alongside Ted, she helped transform how ALS/MND care is delivered worldwide. At a time when patients were often offered little more than prognosis, they envisioned something fundamentally different: coordinated, team-based care grounded in clinical excellence and compassion. Their work helped establish the global standard for multidisciplinary ALS/MND clinics and laid the foundation for the collaborative international community that exists today.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period will open on July 1. 

Primary Sidebar

  • Purningam Jacob, India

    Purningam Jacob, India

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • JP

    JP

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Liam Dwyer, England

    Liam Dwyer, England

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Steve

    Steve

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Ian Gale, Australia

    Ian Gale, Australia

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • David Hall, USA

    David Hall, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Liam Dwyer, England

    Liam Dwyer, England

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Len Johnrose, England

    Len Johnrose, England

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Rosie Riley, USA

    Rosie Riley, USA

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Michael Lee, Australia

    Michael Lee, Australia

  • Daniel Hare, USA

    Daniel Hare, USA

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • John Sweeney, USA

    John Sweeney, USA

  • Lombana, Spain

    Lombana, Spain

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login